Characteristics and one-year outcomes of patients with advanced atrioventricular block in Saudi Arabia: A single-center retrospective cohort study.

IF 1.7 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Saudi Medical Journal Pub Date : 2024-10-01 DOI:10.15537/smj.2024.45.10.20240239

Wael A Alqarawi, Abdulrahman S Alarifi

{"title":"Characteristics and one-year outcomes of patients with advanced atrioventricular block in Saudi Arabia: A single-center retrospective cohort study.","authors":"Wael A Alqarawi, Abdulrahman S Alarifi","doi":"10.15537/smj.2024.45.10.20240239","DOIUrl":null,"url":null,"abstract":"Objectives: To report and describe the characteristics and outcomes of patients with advanced atrioventricular block (AVB) in Saudi Arabia.Methods: We included consecutive patients who underwent pacemaker implantation at King Khaled University Hospital, Riyadh, Saudi Arabia, for advanced AVB, which was defined as second degree type 2 AVB, third degree AVB, and symptomatic atrial fibrillation with slow ventricular response. The variable \"young patient\" was defined as age of 60 or less, based on guidelines recommending cardiac sarcoidosis (CS) evaluation at this age or younger.Results: Among 100 patients (median age: 71 males, 51%), 29 (29%) were young patients. Most patients had at least one comorbidity including hypertension, diabetes, or dyslipidemia (81%). Young patients constituted 26.6% (n=21/79) of idiopathic AVB cases and only 23.8% (n=8/21) underwent CS evaluation (8/21).Conclusion: A significant proportion of AVB occurs in young patients. Yet, CS is often not ruled out. Future studies should define the yield of CS evaluation in the Saudi population when international consensus documents are followed.","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463576/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15537/smj.2024.45.10.20240239","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To report and describe the characteristics and outcomes of patients with advanced atrioventricular block (AVB) in Saudi Arabia.

Methods: We included consecutive patients who underwent pacemaker implantation at King Khaled University Hospital, Riyadh, Saudi Arabia, for advanced AVB, which was defined as second degree type 2 AVB, third degree AVB, and symptomatic atrial fibrillation with slow ventricular response. The variable "young patient" was defined as age of 60 or less, based on guidelines recommending cardiac sarcoidosis (CS) evaluation at this age or younger.

Results: Among 100 patients (median age: 71 males, 51%), 29 (29%) were young patients. Most patients had at least one comorbidity including hypertension, diabetes, or dyslipidemia (81%). Young patients constituted 26.6% (n=21/79) of idiopathic AVB cases and only 23.8% (n=8/21) underwent CS evaluation (8/21).

Conclusion: A significant proportion of AVB occurs in young patients. Yet, CS is often not ruled out. Future studies should define the yield of CS evaluation in the Saudi population when international consensus documents are followed.

查看原文本刊更多论文

沙特阿拉伯晚期房室传导阻滞患者的特征和一年后的预后：单中心回顾性队列研究。

目的：报告并描述沙特阿拉伯晚期房室传导阻滞（AVB）患者的特征和治疗效果：报告并描述沙特阿拉伯晚期房室传导阻滞（AVB）患者的特征和预后：我们纳入了在沙特阿拉伯利雅得哈立德国王大学医院因晚期房室传导阻滞而接受起搏器植入手术的连续患者，晚期房室传导阻滞被定义为二度二型房室传导阻滞、三度房室传导阻滞和伴有缓慢心室反应的无症状心房颤动。年轻患者 "变量的定义是年龄在 60 岁或以下，因为指南建议在这个年龄或更年轻时对心脏肉瘤病（CS）进行评估：在 100 名患者（中位年龄：71 名男性，51%）中，29 名（29%）是年轻患者。大多数患者至少有一种合并症，包括高血压、糖尿病或血脂异常（81%）。年轻患者占特发性房室传导阻滞病例的 26.6%（21/79），只有 23.8%（8/21）的患者接受了 CS 评估（8/21）：结论：很大一部分 AVB 发生在年轻患者身上。结论：有相当一部分 AVB 发生在年轻患者身上，但 CS 往往未被排除。今后的研究应确定在遵循国际共识文件的情况下，沙特人群的 CS 评估率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Saudi Medical Journal 医学-医学：内科

CiteScore

2.30

自引率

6.20%

发文量

203

审稿时长

12 months

期刊介绍： The Saudi Medical Journal is a monthly peer-reviewed medical journal. It is an open access journal, with content released under a Creative Commons attribution-noncommercial license. The journal publishes original research articles, review articles, Systematic Reviews, Case Reports, Brief Communication, Brief Report, Clinical Note, Clinical Image, Editorials, Book Reviews, Correspondence, and Student Corner.